| İçeriden Öğrenenlerin Hisseleri | 14.039.011 shares |
İçeriden Öğrenenlerin Eğilim Skoru
İçeriden Öğrenenlerin Eğilim Skoru, kurumsal içeriden öğrenenler tarafından satın alınan şirketleri bulur.
En yüksek düzeyde içeriden öğrenen birikimine sahip şirketleri tanımlayan karmaşık, çok faktörlü kantitatif bir modelin sonucudur. Skorlama modeli, önceki 90 günde satın alan içeriden öğrenenlerin net sayısının, float yüzde olarak satın alınan toplam hisselerin ve içeriden öğrenenlerin sahip olduğu toplam hisselerin bir kombinasyonunu kullanıyor. Sayı 0 ila 100 arasında değişir; daha yüksek sayılar, emsallerine göre daha yüksek bir birikim düzeyine işaret eder ve 50 ortalamadır.
Güncelleme Sıklığı: Günlük
Şirket Yetkilisi Eğilim Skoru
Şirket Yetkilisi Eğilim Skoru, Kurumsal Şirket Yetkilileri tarafından satın alınan şirketleri bulur.
Tanım gereği Kurumsal Yetkililer, Kurumsal İçeriden Öğrenenlerdir, ancak diğer İçeriden Öğrenenlerin (% 10 Hissedarlar ve Yönetim Kurulu Üyeleri) aksine, Şirket Yetkilileri günlük olarak şirket için çalışırlar ve alım satım yaparken kendi paralarını kullanırlar . (%10 Hissedarlar ve Yönetim Kurulu Üyeleri genellikle başkalarının parasını yöneten fon yöneticileridir.) Bu sebeple, Şirket Yetkilileri tarafından yapılan içeriden öğrenenlerin ticareti çok daha önemlidir ve uygun şekilde ele alınmalıdır.
İçeriden Öğrenenlerin Eğilim Skoru gibi, Şirket Yetkilileri Eğilim Skoru en yüksek düzeyde şirket yetkilisi birikimine sahip şirketleri belirleyen gelişmiş, çok faktörlü kantitatif bir modelin sonucudur.
Güncelleme Sıklığı: Günlük
Anahtar İçeriden Öğrenen Metrikleri
Bu kart, şirketin çeşitli içeriden öğrenilen ölçümlere kıyasla nasıl sıralandığını gösterir. Yüzdelik sıralama, bu şirketin ABD pazarındaki diğer şirketlerle nasıl karşılaştırıldığını gösterir. Daha yüksek sıralamalar daha iyi durumların göstergesidir.
Örneğin, içeriden öğrenen alımlarının olumlu bir gösterge olduğu genel olarak kabul edilir, bu sebeple içeriden öğrenenlerin alımının daha yüksek olduğu şirketler, içeriden satın alan (hatta içeriden öğrenenlerin satışı) daha az olan şirketlere göre daha üst sıralarda yer alır.
Alım Yapan İçeriden Öğrenen Net Sayısı (Sıra)
N/A
Alım Yapan İçeriden Öğrenen Net Sayısı, alım yapan içeriden öğrenenlerin toplam sayısından son 90 gün içinde satış yapan içeriden öğrenenlerin toplam sayısı çıkarılarak elde edilir. Yüzdelik sıralama burada gösterilir (%0 ile %100 arası).
İçeriden Öğrenenler Tarafından Satın Alınan Float Yüzdesi (Sıra)
N/A
İçerden Öğrenenler Tarafından Satın Alınan Float Yüzdesi, içeriden öğrenenler tarafından satın alınan toplam hisse sayısından, son 90 gün içinde içeriden öğrenenler tarafından satılan toplam hisse sayısı çıkarılarak elde edilen toplam floata bölünür ve 100 ile çarpılır.
İçeriden Öğrenenlerin Ticareti Tablosu
Ra Pharmaceuticals, Inc. içeriden öğrenenlerin ticareti aşağıdaki grafikte gösterilmektedir. İçeriden öğrenenler bir şirketteki yetkililer, yöneticiler veya önemli yatırımcılardır. Genel olarak, içeriden öğrenenlerin maddi, kamuya açıklanmamış bilgilere dayanarak şirketlerinde alım satım yapması genellikle yasa dışıdır. Bu onların kendi şirketlerinde herhangi bir işlem yapmalarının yasa dışı olduğu anlamına gelmez. Ancak tüm işlemleri Form 4 aracılığıyla SECye bildirilmesi gerekir.
İçeriden Öğrenenlerin Listesi ve Kârlılık Metrikleri
Bu tablo bilindik içeriden öğrenenlerin listesini gösterir ve SECye bildirilen dosyalardan otomatik olarak oluşturulur. İsimlere ek olarak, en son unvana ve yönetici, yetkili veya %10luk sahiplik tanımına ek olarak, açıklanan en son varlıkları da sağlıyoruz. Ek olarak, mümkün olduğunda içeriden öğrenen için geçmiş ticari performansı da sağlıyoruz. Geçmiş ticari performans, içeriden öğrenenlerin yaptığı gerçek açık piyasa satın alma işlemlerinin performansının ağırlıklı ortalamasıdır. Bunun nasıl hesaplandığı hakkında daha fazla bilgi için bu YouTube web seminerini izleyiniz.
See our leaderboard of most profitable insider traders.
| İçeriden Öğrenen | Ort Kâr (%) | Sahibi Olan Hisseler |
Bölünmüş Düzeltilmiş |
|---|
Report errors via our new Insider Auditing Tool
İçeriden Öğrenenlerin Alımlarının Takip Kayıtları - Kısa Vadeli Kâr Analizi
Bu bölümde, RARX / Ra Pharmaceuticals, Inc. yılında yapılmış her planlanmamış, açık piyasada içeriden öğrenlenlerin satın almalarının kârlılığını analiz ediyoruz. Bu analiz, içeriden öğrenen kişinin sürekli olarak anormal getiriler sağlayıp sağlamadığını ve takip edilmeye değer olup olmadığını anlamaya yardımcı olur. Bu analiz her işlemin ardından bir yıl süreyle geçerlidir ve sonuçlar teoriktir .
Aşağıdaki tablo, otomatik ticaret planının parçası olmayan en son açık piyasa alımlarını göstermektedir.
Düzeltilmiş Fiyat bölünmüş olarak düzeltilmiş fiyattır. Düzeltilmiş Hisseler bölünmüş olarak düzeltilmiş hisselerdir.
İçeriden Öğrenen Satışlarının Takip Kayıtları - Kısa Vadeli Zarar Analizi
Bu bölümde, RARX / Ra Pharmaceuticals, Inc. yılında yapılan her planlanmamış, açık piyasa içeriden öğrenilen satışın kısa vadeli zarardan kaçınma miktarını analiz ediyoruz. Tutarlı bir kayıptan kaçınma modeli, gelecekteki satış işlemlerinin fiyattaki düşüşleri öngörebileceğini düşündürebilir. Bu analiz her işlemin ardından bir yıl süreyle geçerlidir ve sonuçlar teoriktir .
Aşağıdaki tablo, otomatik ticaret planının parçası olmayan en son açık piyasa satışlarını göstermektedir.
Düzeltilmiş Fiyat bölünmüş olarak düzeltilmiş fiyattır. Düzeltilmiş Hisseler bölünmüş olarak düzeltilmiş hisselerdir.
İşlem Geçmişi
Tam işlem geçmişini görmek için bağlantı simgesine tıklayın. 10b5-1 otomatik işlem planı kapsamında bildirilen işlemlerin 10b-5 ile işaretli sütununda X işareti bulunacaktır.
| Dosya Tarih |
Ticaret Tarihi |
Form | İçeriden Öğrenenler | Ticker | Menkul Kıymet Başlığı | Kod | Doğrudan | İşleme Koyma Fiyatı |
Birim Fiyatı |
Birimler Değiştirildi |
Değer Değiştirildi (1K) |
Geriye Kalan Opsiyonlar |
Geriye Kalan Hisseler |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-04-03 | 2020-04-02 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | -6.135.234 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | Brennan Aoife | RARX | Stock Option (Right to Buy) | D | 16,36 | -25.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Brennan Aoife | RARX | Stock Option (Right to Buy) | D | 19,88 | -15.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | RA CAPITAL MANAGEMENT, LLC | RARX | Common Stock | I | 48,0000 | -4.858.260 | -233.196 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | Heft Robert | RARX | Stock Option (Right to Buy) | D | 22,37 | -15.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Heft Robert | RARX | Stock Option (Right to Buy) | D | 19,88 | -15.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Heft Robert | RARX | Stock Option (Right to Buy) | D | 9,90 | -15.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Heft Robert | RARX | Stock Option (Right to Buy) | D | 2,87 | -22.857 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Shah Rajeev M. | RARX | Stock Option (Right to Buy) | D | 19,88 | -15.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Shah Rajeev M. | RARX | Stock Option (Right to Buy) | D | 22,37 | -15.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Shah Rajeev M. | RARX | Stock Option (Right to Buy) | D | 9,90 | -15.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Shah Rajeev M. | RARX | Common Stock | I | 48,0000 | -4.858.260 | -233.196 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | King John C | RARX | Restricted Stock Units | D | -30.658 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | King John C | RARX | Stock Option (Right to Buy) | D | 21,00 | -107.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | King John C | RARX | Stock Option (Right to Buy) | D | 6,20 | -190.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | King John C | RARX | Common Stock | D | 48,0000 | -10.823 | -520 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | PEARSON TIMOTHY R | RARX | Stock Option (Right to Buy) | D | 22,37 | -15.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | PEARSON TIMOTHY R | RARX | Stock Option (Right to Buy) | D | 19,88 | -15.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | PEARSON TIMOTHY R | RARX | Stock Option (Right to Buy) | D | 9,90 | -15.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | PEARSON TIMOTHY R | RARX | Stock Option (Right to Buy) | D | 2,87 | -22.857 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Cumbo Alexander | RARX | Stock Option (Right to Buy) | D | 12,99 | -25.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Cumbo Alexander | RARX | Stock Option (Right to Buy) | D | 19,88 | -15.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Restricted Stock Units | D | -10.416 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Stock Option (Right to Buy) | D | 21,00 | -133.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Stock Option (Right to Buy) | D | 7,33 | -62.500 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Stock Option (Right to Buy) | D | 16,64 | -90.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Stock Option (Right to Buy) | D | 5,60 | -73.654 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Stock Option (Right to Buy) | D | 5,60 | -11.110 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Common Stock | D | 48,0000 | -14.492 | -696 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Restricted Stock Units | D | -9.166 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Stock Option (Right to Buy) | D | 21,00 | -107.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Stock Option (Right to Buy) | D | 7,33 | -55.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Stock Option (Right to Buy) | D | 16,64 | -67.500 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Stock Option (Right to Buy) | D | 5,60 | -25.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Stock Option (Right to Buy) | D | 2,87 | -26.422 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Stock Option (Right to Buy) | D | 2,87 | -46.434 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Common Stock | D | 48,0000 | -12.595 | -605 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Restricted Stock Units | D | -4.375 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 21,00 | -107.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 7,33 | -26.250 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 16,64 | -60.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 5,60 | -31.428 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 2,87 | -30.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 2,87 | -14.285 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 0,84 | -2.857 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Common Stock | D | 48,0000 | -2.973 | -143 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Restricted Stock Units | D | -10.416 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Stock Option (Right to Buy) | D | 21,00 | -133.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Stock Option (Right to Buy) | D | 7,33 | -62.500 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Stock Option (Right to Buy) | D | 16,64 | -112.500 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Stock Option (Right to Buy) | D | 5,60 | -28.571 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Stock Option (Right to Buy) | D | 2,87 | -92.283 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Stock Option (Right to Buy) | D | 2,87 | -115.572 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Common Stock | D | 48,0000 | -15.622 | -750 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Restricted Stock Units | D | -20.833 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Stock Option (Right to Buy) | D | 21,00 | -311.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Stock Option (Right to Buy) | D | 7,33 | -125.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Stock Option (Right to Buy) | D | 16,64 | -225.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Stock Option (Right to Buy) | D | 5,60 | -164.285 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Stock Option (Right to Buy) | D | 2,87 | -241.460 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Stock Option (Right to Buy) | D | 2,87 | -139.371 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Common Stock | D | 48,0000 | -234.707 | -11.266 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | Mathers Edward T | RARX | Stock Option (Right to Buy) | D | 22,37 | -15.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Mathers Edward T | RARX | Stock Option (Right to Buy) | D | 19,88 | -15.000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Mathers Edward T | RARX | Stock Option (Right to Buy) | D | 9,90 | -15.000 | 0 | |||||
| 2020-03-18 | 2020-03-16 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9.206 | 73.654 | |||||
| 2020-03-18 | 2020-03-16 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1.389 | 11.110 | |||||
| 2020-03-18 | 2020-03-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 45,1648 | -10.595 | -479 | 7.132 | ||||
| 2020-03-18 | 2020-03-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9.206 | 52 | 17.727 | ||||
| 2020-03-18 | 2020-03-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1.389 | 8 | 8.521 | ||||
| 2020-03-18 | 2020-03-17 | 4 | Ricardo Alonso | RARX | COMMON STOCK | D | 44,2500 | -2.288 | -101 | 0 | ||||
| 2020-02-20 | 2020-02-18 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9.206 | 82.860 | |||||
| 2020-02-20 | 2020-02-18 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1.389 | 12.499 | |||||
| 2020-02-20 | 2020-02-18 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 46,6116 | -10.595 | -494 | 7.132 | ||||
| 2020-02-20 | 2020-02-18 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9.206 | 52 | 17.727 | ||||
| 2020-02-20 | 2020-02-18 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1.389 | 8 | 8.521 | ||||
| 2020-01-21 | 2020-01-17 | 4 | Ricardo Alonso | RARX | COMMON STOCK | D | 47,0200 | -2.285 | -107 | 2.288 | ||||
| 2020-01-16 | 2020-01-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9.206 | 92.066 | |||||
| 2020-01-16 | 2020-01-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1.389 | 13.888 | |||||
| 2020-01-16 | 2020-01-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 46,9505 | -10.595 | -497 | 7.132 | ||||
| 2020-01-16 | 2020-01-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9.206 | 52 | 17.727 | ||||
| 2020-01-16 | 2020-01-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1.389 | 8 | 8.521 | ||||
| 2019-12-18 | 2019-12-16 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9.206 | 101.272 | |||||
| 2019-12-18 | 2019-12-16 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1.389 | 15.277 | |||||
| 2019-12-18 | 2019-12-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 47,2252 | -10.595 | -500 | 7.132 | ||||
| 2019-12-18 | 2019-12-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9.206 | 52 | 17.727 | ||||
| 2019-12-18 | 2019-12-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1.389 | 8 | 8.521 | ||||
| 2019-12-18 | 2019-12-17 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2,87 | -10.000 | 46.142 | |||||
| 2019-12-18 | 2019-12-17 | 4 | Read Simon | RARX | COMMON STOCK | D | 47,0821 | -10.000 | -471 | 6.234 | ||||
| 2019-12-18 | 2019-12-17 | 4 | Read Simon | RARX | COMMON STOCK | D | 2,8700 | 10.000 | 29 | 16.234 | ||||
| 2019-12-18 | 2019-12-17 | 4 | Ricardo Alonso | RARX | COMMON STOCK | D | 47,0759 | -2.285 | -108 | 4.573 | ||||
| 2019-11-18 | 2019-11-14 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2,87 | -10.000 | 56.142 | |||||
| 2019-11-18 | 2019-11-14 | 4 | Read Simon | RARX | COMMON STOCK | D | 46,6808 | -10.000 | -467 | 6.234 | ||||
| 2019-11-18 | 2019-11-14 | 4 | Read Simon | RARX | COMMON STOCK | D | 2,8700 | 10.000 | 29 | 16.234 | ||||
| 2019-11-18 | 2019-11-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9.206 | 110.478 | |||||
| 2019-11-18 | 2019-11-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1.389 | 16.666 | |||||
| 2019-11-18 | 2019-11-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 46,6559 | -10.595 | -494 | 7.132 | ||||
| 2019-11-18 | 2019-11-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9.206 | 52 | 17.727 | ||||
| 2019-11-18 | 2019-11-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1.389 | 8 | 8.521 | ||||
| 2019-10-17 | 2019-10-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9.206 | 119.684 | |||||
| 2019-10-17 | 2019-10-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1.389 | 18.055 | |||||
| 2019-10-17 | 2019-10-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 46,8871 | -10.595 | -497 | 7.132 | ||||
| 2019-10-17 | 2019-10-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9.206 | 52 | 17.727 | ||||
| 2019-10-17 | 2019-10-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1.389 | 8 | 8.521 | ||||
| 2019-10-17 | 2019-10-16 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2,87 | -10.000 | 66.142 | |||||
| 2019-10-17 | 2019-10-16 | 4 | Read Simon | RARX | COMMON STOCK | D | 46,8726 | -10.000 | -469 | 6.234 | ||||
| 2019-10-17 | 2019-10-16 | 4 | Read Simon | RARX | COMMON STOCK | D | 2,8700 | 10.000 | 29 | 16.234 | ||||
| 2019-10-17 | 2019-10-17 | 4 | Ricardo Alonso | RARX | COMMON STOCK | D | 46,7000 | -2.285 | -107 | 6.858 | ||||
| 2019-09-16 | 2019-09-12 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2,87 | -10.000 | 76.142 | |||||
| 2019-09-16 | 2019-09-12 | 4 | Read Simon | RARX | COMMON STOCK | D | 25,4050 | -10.000 | -254 | 6.234 | ||||
| 2019-09-16 | 2019-09-12 | 4 | Read Simon | RARX | COMMON STOCK | D | 2,8700 | 10.000 | 29 | 16.234 | ||||
| 2019-09-16 | 2019-09-16 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9.206 | 128.890 | |||||
| 2019-09-16 | 2019-09-16 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1.389 | 19.444 | |||||
| 2019-09-16 | 2019-09-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 25,2643 | -10.595 | -268 | 7.132 | ||||
| 2019-09-16 | 2019-09-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9.206 | 52 | 17.727 | ||||
| 2019-09-16 | 2019-09-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1.389 | 8 | 8.521 | ||||
| 2019-08-27 | 2019-08-23 | 4 | Ricardo Alonso | RARX | COMMON STOCK | D | 27,8949 | -2.285 | -64 | 9.143 | ||||
| 2019-08-27 | 2019-08-23 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9.206 | 138.096 | |||||
| 2019-08-27 | 2019-08-23 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1.389 | 20.833 | |||||
| 2019-08-27 | 2019-08-23 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 27,7703 | -10.595 | -294 | 7.132 | ||||
| 2019-08-27 | 2019-08-23 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9.206 | 52 | 17.727 | ||||
| 2019-08-27 | 2019-08-23 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1.389 | 8 | 8.521 | ||||
| 2019-08-27 | 2019-08-23 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2,87 | -10.000 | 86.142 | |||||
| 2019-08-27 | 2019-08-23 | 4 | Read Simon | RARX | COMMON STOCK | D | 27,7703 | -10.000 | -278 | 6.234 | ||||
| 2019-08-27 | 2019-08-23 | 4 | Read Simon | RARX | COMMON STOCK | D | 2,8700 | 10.000 | 29 | 16.234 | ||||
| 2019-07-18 | 2019-07-17 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2,87 | -10.000 | 96.142 | |||||
| 2019-07-18 | 2019-07-17 | 4 | Read Simon | RARX | COMMON STOCK | D | 32,9479 | -10.000 | -329 | 6.234 | ||||
| 2019-07-18 | 2019-07-17 | 4 | Read Simon | RARX | COMMON STOCK | D | 2,8700 | 10.000 | 29 | 16.234 | ||||
| 2019-07-16 | 2019-07-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9.206 | 147.302 | |||||
| 2019-07-16 | 2019-07-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1.389 | 22.222 | |||||
| 2019-07-16 | 2019-07-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 33,2870 | -4.216 | -140 | 7.132 | ||||
| 2019-07-16 | 2019-07-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 32,9690 | -6.379 | -210 | 11.348 | ||||
| 2019-07-16 | 2019-07-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9.206 | 52 | 17.727 | ||||
| 2019-07-16 | 2019-07-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1.389 | 8 | 8.521 | ||||
| 2019-06-25 | 2019-06-21 | 4 | Ricardo Alonso | RARX | COMMON STOCK | D | 23,7248 | -2.857 | -68 | 11.428 | ||||
| 2019-06-19 | 2019-06-17 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -9.206 | 156.508 | |||||
| 2019-06-19 | 2019-06-17 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5,60 | -1.389 | 23.611 | |||||
| 2019-06-19 | 2019-06-17 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 22,0439 | -7.184 | -158 | 7.132 | ||||
| 2019-06-19 | 2019-06-17 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 21,4074 | -3.411 | -73 | 14.316 | ||||
| 2019-06-19 | 2019-06-17 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 9.206 | 52 | 17.727 | ||||
| 2019-06-19 | 2019-06-17 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5,6000 | 1.389 | 8 | 8.521 | ||||
| 2019-06-19 | 2019-06-18 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2,87 | -10.000 | 106.142 | |||||
| 2019-06-19 | 2019-06-18 | 4 | Read Simon | RARX | COMMON STOCK | D | 23,0906 | -414 | -10 | 6.234 | ||||
| 2019-06-19 | 2019-06-18 | 4 | Read Simon | RARX | COMMON STOCK | D | 22,2103 | -9.586 | -213 | 6.648 | ||||
| 2019-06-19 | 2019-06-18 | 4 | Read Simon | RARX | COMMON STOCK | D | 2,8700 | 10.000 | 29 | 16.234 | ||||
| 2019-06-13 | 2019-06-11 | 4 | RA CAPITAL MANAGEMENT, LLC | RARX | Director Options to Purchase Common Stock (right to buy) | I | 19,88 | 15.000 | 15.000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | Heft Robert | RARX | Option to Purchase Common Stock | D | 19,88 | 15.000 | 15.000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | Brennan Aoife | RARX | Option to Purchase Common Stock | D | 19,88 | 15.000 | 15.000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | PEARSON TIMOTHY R | RARX | Option to Purchase Common Stock | D | 19,88 | 15.000 | 15.000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | Cumbo Alexander | RARX | Option to Purchase Common Stock | D | 19,88 | 15.000 | 15.000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | Shah Rajeev M. | RARX | Option to Purchase Common Stock | D | 19,88 | 15.000 | 15.000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | Mathers Edward T | RARX | Option to Purchase Common Stock | D | 19,88 | 15.000 | 15.000 | |||||
| 2019-04-18 | 2019-04-16 | 4 | King John C | RARX | Restricted Stock Units | D | -15.329 | 30.658 | ||||||
| 2019-04-18 | 2019-04-16 | 4 | King John C | RARX | Common Stock | D | 21,9300 | -4.506 | -99 | 10.823 | ||||
| 2019-04-18 | 2019-04-16 | 4 | King John C | RARX | Common Stock | D | 15.329 | 15.329 | ||||||
| 2019-03-06 | 3 | Ricardo Alonso | RARX | Common Stock | D | 28.570 | ||||||||
| 2019-03-06 | 3 | Ricardo Alonso | RARX | Common Stock | D | 28.570 | ||||||||
| 2019-03-06 | 3 | Ricardo Alonso | RARX | Common Stock | D | 28.570 | ||||||||
| 2019-02-05 | 2019-02-01 | 4 | Treco Douglas A | RARX | Restricted Stock Units | D | -20.834 | 41.666 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Treco Douglas A | RARX | Options to Purchase Common Stock | D | 21,00 | 311.000 | 311.000 | |||||
| 2019-02-05 | 2019-02-01 | 4 | Treco Douglas A | RARX | COMMON STOCK | D | 21,0000 | -6.327 | -133 | 218.799 | ||||
| 2019-02-05 | 2019-02-01 | 4 | Treco Douglas A | RARX | COMMON STOCK | D | 20.834 | 225.126 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Farzaneh-Far Ramin | RARX | Restricted Stock Units | D | -10.417 | 20.833 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Farzaneh-Far Ramin | RARX | Options to Purchase Common Stock | D | 21,00 | 133.000 | 133.000 | |||||
| 2019-02-05 | 2019-02-01 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 21,0000 | -3.285 | -69 | 7.132 | ||||
| 2019-02-05 | 2019-02-01 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 10.417 | 10.417 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Read Simon | RARX | Restricted Stock Units | D | -9.167 | 18.333 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Read Simon | RARX | Options to Purchase Common Stock | D | 21,00 | 107.000 | 107.000 | |||||
| 2019-02-05 | 2019-02-01 | 4 | Read Simon | RARX | COMMON STOCK | D | 21,0000 | -2.933 | -62 | 6.234 | ||||
| 2019-02-05 | 2019-02-01 | 4 | Read Simon | RARX | COMMON STOCK | D | 9.167 | 9.167 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Lubner David Charles | RARX | Restricted Stock Units | D | -10.417 | 20.833 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Lubner David Charles | RARX | Options to Purchase Common Stock | D | 21,00 | 133.000 | 133.000 | |||||
| 2019-02-05 | 2019-02-01 | 4 | Lubner David Charles | RARX | COMMON STOCK | D | 21,0000 | -3.291 | -69 | 7.126 | ||||
| 2019-02-05 | 2019-02-01 | 4 | Lubner David Charles | RARX | COMMON STOCK | D | 10.417 | 10.417 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | King John C | RARX | Options to Purchase Common Stock | D | 21,00 | 107.000 | 107.000 | |||||
| 2018-12-14 | 2018-12-12 | 4 | RA CAPITAL MANAGEMENT, LLC | RARX | Common Stock | I | 15,5000 | 1.006.452 | 15.600 | 4.858.260 | ||||
| 2018-12-14 | 2018-12-14 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 15,5000 | 645.161 | 10.000 | 6.135.234 | ||||
| 2018-12-14 | 2018-12-14 | 4 | Shah Rajeev M. | RARX | Common Stock | I | 15,5000 | 1.006.452 | 15.600 | 4.858.260 | ||||
| 2018-11-15 | 2018-11-14 | 4 | Cumbo Alexander | RARX | Option to Purchase Common Stock | D | 12,99 | 25.000 | 25.000 | |||||
| 2018-11-01 | 2018-06-28 | 4 | RA CAPITAL MANAGEMENT, LLC | RARX | Director Options to Purchase Common Stock (right to buy) | I | 9,90 | 15.000 | 15.000 | |||||
| 2018-09-25 | 2018-09-21 | 4 | Brennan Aoife | RARX | Options to Purchase Common Stock | D | 16,36 | 25.000 | 25.000 | |||||
| 2018-07-02 | 2018-06-28 | 4 | RA CAPITAL MANAGEMENT, LLC | RARX | Director Options to Purchase Common Stock (right to buy) | I | 9,90 | 15.000 | 15.000 | |||||
| 2018-07-02 | 2018-06-28 | 4 | Mathers Edward T | RARX | Options to Purchase Common Stock | D | 9,90 | 15.000 | 15.000 | |||||
| 2018-07-02 | 2018-06-28 | 4 | Shah Rajeev M. | RARX | Options to Purchase Common Stock | D | 9,90 | 15.000 | 15.000 | |||||
| 2018-07-02 | 2018-06-28 | 4 | Bisgaard Peter | RARX | Options to Purchase Common Stock | D | 9,90 | 15.000 | 15.000 | |||||
| 2018-07-02 | 2018-06-28 | 4 | PEARSON TIMOTHY R | RARX | Options to Purchase Common Stock | D | 9,90 | 15.000 | 15.000 | |||||
| 2018-07-02 | 2018-06-28 | 4 | Heft Robert | RARX | Options to Purchase Common Stock | D | 9,90 | 15.000 | 15.000 | |||||
| 2018-05-02 | 2018-05-01 | 4 | King John C | RARX | Restricted Stock Units | D | 45.987 | 45.987 | ||||||
| 2018-05-02 | 2018-05-01 | 4 | King John C | RARX | Option to Purchase Common Stock | D | 6,20 | 190.000 | 190.000 | |||||
| 2018-02-21 | 2018-02-16 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 6,0000 | 2.000.000 | 12.000 | 5.490.073 | ||||
| 2018-02-16 | 2018-02-14 | 4 | RA CAPITAL MANAGEMENT, LLC See Note | RARX | Common Stock | I | 6,0000 | 2.500.000 | 15.000 | 3.851.808 | ||||
| 2018-02-16 | 2018-02-14 | 4 | Shah Rajeev M. | RARX | Common Stock | I | 6,0000 | 2.500.000 | 15.000 | 3.851.808 | ||||
| 2018-02-05 | 2018-02-01 | 4 | Treco Douglas A | RARX | Restricted Stock Units | D | 0,00 | 62.500 | 62.500 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Treco Douglas A | RARX | Options to Purchase Common Stock | D | 7,33 | 125.000 | 125.000 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Lubner David Charles | RARX | Restricted Stock Units | D | 0,00 | 31.250 | 31.250 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Lubner David Charles | RARX | Options to Purchase Common Stock | D | 7,33 | 62.500 | 62.500 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Read Simon | RARX | Restricted Stock Unit | D | 0,00 | 27.500 | 27.500 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Read Simon | RARX | Options to Purchase Common Stock | D | 7,33 | 55.000 | 55.000 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Farzaneh-Far Ramin | RARX | Restricted Stock Unit | D | 0,00 | 31.250 | 31.250 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Farzaneh-Far Ramin | RARX | Options to Purchase Common Stock | D | 7,33 | 62.500 | 62.500 | |||||
| 2017-10-30 | 2017-10-26 | 4 | Bisgaard Peter | RARX | Options to Purchase Common Stock | D | 22,37 | 15.000 | 15.000 | |||||
| 2017-06-22 | 2017-06-20 | 4 | Lettmann Jason | RARX | Options to Purchase Common Stock | D | 22,37 | 15.000 | 15.000 | |||||
| 2017-06-22 | 2017-06-20 | 4 | Mathers Edward T | RARX | Options to Purchase Common Stock | D | 22,37 | 15.000 | 15.000 | |||||
| 2017-06-22 | 2017-06-20 | 4 | PEARSON TIMOTHY R | RARX | Options to Purchase Common Stock | D | 22,37 | 15.000 | 15.000 | |||||
| 2017-06-22 | 2017-06-20 | 4 | Shah Rajeev M. | RARX | Options to Purchase Common Stock | D | 22,37 | 15.000 | 15.000 | |||||
| 2017-06-22 | 2017-06-20 | 4 | Heft Robert | RARX | Options to Purchase Common Stock | D | 22,37 | 15.000 | 15.000 | |||||
| 2017-06-22 | 2017-06-20 | 4 | RA CAPITAL MANAGEMENT, LLC See Footnotes | RARX | Director Options to Purchase Common Stock (right to buy) | I | 22,37 | 15.000 | 15.000 | |||||
| 2017-06-20 | 2017-06-19 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 22,0182 | -3.220 | -71 | 2.251.457 | ||||
| 2017-06-20 | 2017-06-16 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 21,2445 | -53.200 | -1.130 | 2.254.677 | ||||
| 2017-06-12 | 2017-06-08 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 22,0000 | -700 | -15 | 2.307.877 | ||||
| 2017-06-08 | 2017-06-07 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 22,1073 | -4.840 | -107 | 2.308.577 | ||||
| 2017-06-08 | 2017-06-06 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 22,9806 | -7.274 | -167 | 2.313.417 | ||||
| 2017-06-06 | 2017-06-05 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 23,1146 | -4.780 | -110 | 2.320.691 | ||||
| 2017-06-06 | 2017-06-02 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 23,4714 | -14.867 | -349 | 2.325.471 | ||||
| 2017-06-02 | 2017-06-01 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 23,8926 | -10.722 | -256 | 2.340.338 | ||||
| 2017-06-02 | 2017-05-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 23,9426 | -35.539 | -851 | 2.351.060 | ||||
| 2017-05-30 | 2017-05-26 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 25,1448 | -5.300 | -133 | 2.386.599 | ||||
| 2017-05-30 | 2017-05-25 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 25,0000 | -53 | -1 | 2.391.899 | ||||
| 2017-05-25 | 2017-05-24 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 25,0051 | -17.451 | -436 | 2.391.952 | ||||
| 2017-05-22 | 2017-05-18 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 25,4977 | -9.019 | -230 | 2.409.403 | ||||
| 2017-05-18 | 2017-05-17 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 25,5126 | -22.534 | -575 | 2.418.422 | ||||
| 2017-05-18 | 2017-05-16 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 26,3296 | -20.081 | -529 | 2.440.956 | ||||
| 2017-05-02 | 2017-03-01 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 20,9126 | -7.778 | -163 | 2.461.037 | ||||
| 2017-05-02 | 2017-02-28 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 20,8577 | -7.847 | -164 | 2.468.815 | ||||
| 2017-05-02 | 2017-02-27 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 20,9582 | -57.844 | -1.212 | 2.476.662 | ||||
| 2017-05-02 | 2017-02-24 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 20,9336 | -5.398 | -113 | 2.534.506 | ||||
| 2017-05-02 | 2017-02-23 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 21,0362 | -4.999 | -105 | 2.539.904 | ||||
| 2017-05-02 | 2017-02-22 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 21,8553 | -749 | -16 | 2.544.903 | ||||
| 2017-02-03 | 2017-02-01 | 4 | Lubner David Charles | RARX | Options to Purchase Common Stock | D | 16,64 | 112.500 | 112.500 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Treco Douglas A | RARX | Options to Purchase Common Stock | D | 16,64 | 225.000 | 225.000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Farzaneh-Far Ramin | RARX | Options to Purchase Common Stock | D | 16,64 | 90.000 | 90.000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Read Simon | RARX | Options to Purchase Common Stock | D | 16,64 | 67.500 | 67.500 | |||||
| 2016-11-02 | 2016-10-31 | 4 | Novo A/S | RARX | Series B-2 Preferred Stock | D | -860.438 | 0 | ||||||
| 2016-11-02 | 2016-10-31 | 4 | Novo A/S | RARX | Series B-1 Preferred Stock | D | -924.970 | 0 | ||||||
| 2016-11-02 | 2016-10-31 | 4 | Novo A/S | RARX | Common Stock | D | 13,0000 | 246.154 | 3.200 | 2.031.562 | ||||
| 2016-11-02 | 2016-10-31 | 4 | Novo A/S | RARX | Common Stock | D | 860.438 | 1.785.408 | ||||||
| 2016-11-02 | 2016-10-31 | 4 | Novo A/S | RARX | Common Stock | D | 924.970 | 924.970 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Series B-2 Preferred Stock | D | -3.402.729 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Series B-1 Preferred Stock | D | -3.657.932 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Series A Preferred Stock | D | -9.728.589 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Warrants to Purchase Common Stock | D | 0,07 | -62.914 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 13,0000 | 84.615 | 1.100 | 2.545.652 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 486.104 | 2.461.037 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 522.561 | 1.974.933 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 1.389.797 | 1.452.372 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 13,0000 | -339 | -4 | 62.575 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 0,0700 | 62.914 | 4 | 62.914 | ||||
| 2016-10-31 | 2016-10-31 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | RARX | Series B-2 Preferred Stock | I | -4.015.378 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | RARX | Series B-1 Preferred Stock | I | -4.316.531 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | RA CAPITAL MANAGEMENT, LLC | RARX | Common Stock | I | 13,0000 | 161.538 | 2.100 | 1.351.808 | ||||
| 2016-10-31 | 2016-10-31 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | RARX | Common Stock | I | 573.624 | 1.190.270 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | RARX | Common Stock | I | 616.646 | 616.646 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Series B-2 Preferred Stock | D | -4.362.472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Series B-1 Preferred Stock | D | -4.689.657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Series A Preferred Stock | D | -12.447.605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Warrants to Purchase Common Stock | D | 0,07 | -80.658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 13,0000 | 338.462 | 4.400 | 3.490.073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 623.210 | 3.151.611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 669.951 | 2.528.401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 1.778.227 | 1.858.450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 13,0000 | -435 | -6 | 80.223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 0,0700 | 80.658 | 6 | 80.658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Series B-2 Preferred Stock | I | -4.362.472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Series B-1 Preferred Stock | I | -4.689.657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Series A Preferred Stock | I | -12.447.605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0,07 | -80.658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Common Stock | I | 13,0000 | 338.462 | 4.400 | 3.490.073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Common Stock | I | 623.210 | 3.151.611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Common Stock | I | 669.951 | 2.528.401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Common Stock | I | 1.778.227 | 1.858.450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Common Stock | I | 13,0000 | -435 | -6 | 80.223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Common Stock | I | 0,0700 | 80.658 | 6 | 80.658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Series B-2 Preferred Stock | I | -4.362.472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Series B-1 Preferred Stock | I | -4.689.657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Series A Preferred Stock | I | -12.447.605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0,07 | -80.658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Common Stock | I | 13,0000 | 338.462 | 4.400 | 3.490.073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Common Stock | I | 623.210 | 3.151.611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Common Stock | I | 669.951 | 2.528.401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Common Stock | I | 1.778.227 | 1.858.450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Common Stock | I | 13,0000 | -435 | -6 | 80.223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Common Stock | I | 0,0700 | 80.658 | 6 | 80.658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Series B-2 Preferred Stock | I | -4.362.472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Series B-1 Preferred Stock | I | -4.689.657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Series A Preferred Stock | I | -12.447.605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0,07 | -80.658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Common Stock | I | 13,0000 | 338.462 | 4.400 | 3.490.073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Common Stock | I | 623.210 | 3.151.611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Common Stock | I | 669.951 | 2.528.401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Common Stock | I | 1.778.227 | 1.858.450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Common Stock | I | 13,0000 | -435 | -6 | 80.223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Common Stock | I | 0,0700 | 80.658 | 6 | 80.658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Series B-2 Preferred Stock | I | -4.362.472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Series B-1 Preferred Stock | I | -4.689.657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Series A Preferred Stock | I | -12.447.605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0,07 | -80.658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Common Stock | I | 13,0000 | 338.462 | 4.400 | 3.490.073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Common Stock | I | 623.210 | 3.151.611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Common Stock | I | 669.951 | 2.528.401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Common Stock | I | 1.778.227 | 1.858.450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Common Stock | I | 13,0000 | -435 | -6 | 80.223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Common Stock | I | 0,0700 | 80.658 | 6 | 80.658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Series B-2 Preferred Stock | I | -4.362.472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Series B-1 Preferred Stock | I | -4.689.657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Series A Preferred Stock | I | -12.447.605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0,07 | -80.658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Common Stock | I | 13,0000 | 338.462 | 4.400 | 3.490.073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Common Stock | I | 623.210 | 3.151.611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Common Stock | I | 669.951 | 2.528.401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Common Stock | I | 1.778.227 | 1.858.450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Common Stock | I | 13,0000 | -435 | -6 | 80.223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Common Stock | I | 0,0700 | 80.658 | 6 | 80.658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Series B-2 Preferred Stock | I | -4.362.472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Series B-1 Preferred Stock | I | -4.689.657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Series A Preferred Stock | I | -12.447.605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0,07 | -80.658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Common Stock | I | 13,0000 | 338.462 | 4.400 | 3.490.073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Common Stock | I | 623.210 | 3.151.611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Common Stock | I | 669.951 | 2.528.401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Common Stock | I | 1.778.227 | 1.858.450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Common Stock | I | 13,0000 | -435 | -6 | 80.223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Common Stock | I | 0,0700 | 80.658 | 6 | 80.658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Series B-2 Preferred Stock | I | -4.362.472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Series B-1 Preferred Stock | I | -4.689.657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Series A Preferred Stock | I | -12.447.605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0,07 | -80.658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Common Stock | I | 13,0000 | 338.462 | 4.400 | 3.490.073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Common Stock | I | 623.210 | 3.151.611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Common Stock | I | 669.951 | 2.528.401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Common Stock | I | 1.778.227 | 1.858.450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Common Stock | I | 13,0000 | -435 | -6 | 80.223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Common Stock | I | 0,0700 | 80.658 | 6 | 80.658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Series B-2 Preferred Stock | I | -4.362.472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Series B-1 Preferred Stock | I | -4.689.657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Series A Preferred Stock | I | -12.447.605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0,07 | -80.658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Common Stock | I | 13,0000 | 338.462 | 4.400 | 3.490.073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Common Stock | I | 623.210 | 3.151.611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Common Stock | I | 669.951 | 2.528.401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Common Stock | I | 1.778.227 | 1.858.450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Common Stock | I | 13,0000 | -435 | -6 | 80.223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Common Stock | I | 0,0700 | 80.658 | 6 | 80.658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Series B-2 Preferred Stock | I | -4.362.472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Series B-1 Preferred Stock | I | -4.689.657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Series A Preferred Stock | I | -12.447.605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0,07 | -80.658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Common Stock | I | 13,0000 | 338.462 | 4.400 | 3.490.073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Common Stock | I | 623.210 | 3.151.611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Common Stock | I | 669.951 | 2.528.401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Common Stock | I | 1.778.227 | 1.858.450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Common Stock | I | 13,0000 | -435 | -6 | 80.223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Common Stock | I | 0,0700 | 80.658 | 6 | 80.658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Lubner David Charles | RARX | Options to Purchase Common Stock | D | 2,87 | 29.285 | 29.285 | |||||
| 2016-10-31 | 2016-10-31 | 4 | Shah Rajeev M. | RARX | Series B-2 Preferred Stock | I | -4.015.378 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Shah Rajeev M. See footnotes | RARX | Series B-1 Preferred Stock | I | -4.316.531 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Shah Rajeev M. | RARX | Common Stock | I | 13,0000 | 161.538 | 2.100 | 1.351.808 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Shah Rajeev M. | RARX | Common Stock | I | 573.624 | 1.190.270 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Shah Rajeev M. See footnotes | RARX | Common Stock | I | 616.646 | 616.646 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Series B-2 Preferred Stock | D | -3.408.439 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Series B-1 Preferred Stock | D | -3.664.071 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Series A Preferred Stock | D | -9.744.916 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Warrants to Purchase Common Stock | D | 0,07 | -63.019 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Common Stock | D | 13,0000 | 263.538 | 3.426 | 2.745.846 | ||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Common Stock | D | 486.919 | 2.482.308 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Common Stock | D | 523.438 | 1.995.389 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Common Stock | D | 1.392.130 | 1.471.951 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Common Stock | D | 13,0000 | -340 | -4 | 79.821 | ||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Common Stock | D | 0,0700 | 63.019 | 4 | 80.161 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series B-2 Preferred Stock | I | -481.503 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series B-1 Preferred Stock | I | -3.533.875 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series B-2 Preferred Stock | I | -517.617 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series B-1 Preferred Stock | I | -3.798.914 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series B-2 Preferred Stock | I | -3.408.439 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series B-1 Preferred Stock | I | -3.664.071 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series A Preferred Stock | I | -9.744.916 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Warrants to Purchase Common Stock | I | 0,07 | -63.019 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 13,0000 | 15.633 | 203 | 4.066.503 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 13,0000 | 114.752 | 1.492 | 4.050.870 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 13,0000 | 263.538 | 3.426 | 3.936.118 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 68.786 | 3.672.580 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 504.839 | 3.603.794 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 73.945 | 3.098.955 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 542.702 | 3.025.010 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 486.919 | 2.482.308 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 523.438 | 1.995.389 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 1.392.130 | 1.471.951 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 13,0000 | -340 | -4 | 79.821 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 0,0700 | 63.019 | 4 | 80.161 | ||||
| 2016-10-25 | 3 | Morgenthaler Management Partners IX, LLC | RARX | Common Stock | D | 34.284 | ||||||||
| 2016-10-25 | 3 | Morgenthaler Management Partners IX, LLC | RARX | Common Stock | D | 34.284 | ||||||||
| 2016-10-25 | 3 | Morgenthaler Management Partners IX, LLC | RARX | Common Stock | D | 34.284 | ||||||||
| 2016-10-25 | 3 | Treco Douglas A | RARX | Common Stock | D | 408.584 | ||||||||
| 2016-10-25 | 3 | Treco Douglas A | RARX | Common Stock | D | 408.584 | ||||||||
| 2016-10-25 | 3 | Lettmann Jason See footnotes | RARX | Common Stock | I | 34.284 | ||||||||
| 2016-10-25 | 3 | Lettmann Jason See footnotes | RARX | Common Stock | I | 34.284 |
P
Türev olmayan veya türev menkul kıymetlerin açık piyasa veya özel alımı
S
Türev olmayan veya türev menkul kıymetlerin açık piyasa veya özel satımı
A
Şirketten menkul kıymetlerin verilmesi, ödüllendirilmesi veya başka şekilde edinilmesi (opsiyon gibi)
C
Türevin dönüşümü
D
Menkul kıymetlerin şirkete geri satışı veya devri
F
Kullanım bedelinin veya vergi yükümlülüğünün şirketten alınan menkul kıymetlerin bir kısmı kullanılarak ödenmesi
G
Menkul kıymetlerin içeriden birine veya kişiye hediye edilmesi
K
Özkaynak swapları ve benzeri riskten korunma işlemleri
M
Şirketten alınan türev menkul kıymetin kullanılması veya dönüştürülmesi (opsiyon gibi)
V
Form 4te gönüllü olarak bildirilen bir işlem
J
Diğer (işlemi açıklayan bir dipnotla birlikte)
